This randomised control trial sponsored by the British Heart Foundation assessed whether transdermal glyceryl trinitrate (GTN) is beneficial to patients experiencing a stroke.
The trial completed recruitment in May 2018, and the results were published in February 2019 in The Lancet (RIGHT-2); Pre-hospital treatment with GTN for patients with presumed stroke does not appear to improve functional outcome.
For more information, please visit the trial website: http://right-2.ac.uk/
Participating Ambulance Services:
|East of England Ambulance Service|
|East Midlands Ambulance Service|
|London Ambulance Service|
|North West Ambulance Service|
|West Midlands Ambulance Service|
|Yorkshire Ambulance Service|
If you’d like to work with ambulance services from across the UK to develop a similar project contact us.